Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Dose of MenABCWY in Adolescents
NCT01367158Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2011
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Novartis. Started Jul 2011; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01367158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367158.